Evaluation of efficacy of steroid eye dropfor macular disease

Not Applicable

• Conditions: macula edema, neovascular eye disease; macular edema; C11.768.725, C23.550.589.500.725

• Registration Number: JPRN-jRCTs041180160
• Lead Sponsor: Yamashita Hidetoshi

Brief Summary

Mean retinal thickness decreased significantly in patients who completed difluprednate ophthalmic emulsion instillation, and retinal thickness decreased by 20% or more in 37% of cases. No serious complications were observed.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-29
• Study Completion: 2021-02-07
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

The patients with mean foveal thickness more than 300 micro meter.

Exclusion Criteria

The patients who have history of elevation of intraocular pressure by using steroid drugs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified